Torrent Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Torrent Pharmaceuticals has called a court-convened meeting of its equity shareholders on April 28, 2026 at 10:00 a.m. (via video conferencing) to seek approval for the amalgamation of J.B. Chemicals & Pharmaceuticals (JB Pharma, the transferor) into Torrent Pharma (the transferee). The meeting was ordered by the NCLT Ahmedabad Bench on March 23, 2026. Torrent has already acquired roughly 7.83 crore equity shares of JB Pharma (including about 74.48 lakh from Tau Investment Holdings and 38.75 lakh from employee shareholders) and has completed the mandatory open offer. The remote e-voting window runs from April 24 to April 27, 2026, with a cut-off date of April 21, 2026. Shareholders as on the cut-off date can vote through CDSL's e-voting platform, and approval requires a majority in number representing three-fourths in value of shareholders voting.
This is a critical procedural step toward completing the JB Pharma–Torrent Pharma merger. If shareholders approve, the scheme will still require final NCLT sanction and other regulatory clearances before becoming effective. Approval would consolidate two large Indian pharma companies under one entity, potentially strengthening Torrent's market position, while rejection could delay or derail the deal.